Australia markets open in 5 hours 5 minutes

AVXL Jan 2024 30.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.05000.0000 (0.00%)
As of 08:56AM EST. Market open.
Full screen
Previous close0.0500
Expiry date2024-01-19
Day's range0.0500 - 0.0500
Contract rangeN/A
Open interest965
  • Insider Monkey

    Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2023 Earnings Call Transcript

    Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2023 Earnings Call Transcript November 27, 2023 Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0.12, expectations were $-0.16. Operator: Good morning, and welcome to the Anavex Life Sciences Fiscal 2023 Fourth Quarter Conference Call. My name is Clint Tomlinson and I will be your host for […]

  • Zacks

    Wall Street Analysts See a 468.83% Upside in Anavex Life Sciences (AVXL): Can the Stock Really Move This High?

    The mean of analysts' price targets for Anavex Life Sciences (AVXL) points to a 468.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

  • GlobeNewswire

    Anavex Life Sciences Reports Fiscal 2023 Year End Financial Results and Provides Business Update

    Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its fiscal year ended